NCT07927283 Fulvic Acid Supplementation and Metabolic Syndrome
| NCT ID | NCT07927283 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Arizona State University |
| Condition | Metabolic Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-11-06 |
| Primary Completion | 2027-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-11-06 with a primary completion date of 2027-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fulvic acid is a naturally occurring compound derived from the decomposition of organic matter in soil over long periods. Fulvic acid complexes, such as MLG-50 (MLG-50® Mineral Logic, Kalamazoo, Michigan), offer a highly concentrated, water-soluble form of fulvic acid that contains over 70 trace minerals and elements. Our preclinical studies have found that a soil derived organic mineral complex rich in fulvic acid prevented the high fat diet induced hyperglycemia, endothelial dysfunction, liver injury, endotoxemia, and gut dysbiosis induced by high-fat feeding in rats. We propose to examine the efficacy of fulvic acid (both 50 mg and 100 mg daily for 12 weeks) in the mitigation of symptoms related to metabolic syndrome.
Eligibility Criteria
Inclusion Criteria: * metabolic syndrome or prediabetes Exclusion Criteria: * pregnant or nursing * multiple medications to treat obesity, heart disease, thyroid conditions, cancer * smokers * competing athletes * vegetarians
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07927283 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Metabolic Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07927283 currently recruiting?
Yes, NCT07927283 is actively recruiting participants. Contact the research team at carol.johnston@asu.edu for enrollment information.
Where is the NCT07927283 trial being conducted?
This trial is being conducted at Phoenix, United States.
Who is sponsoring the NCT07927283 clinical trial?
NCT07927283 is sponsored by Arizona State University. The trial plans to enroll 60 participants.